Skip to main content
SpringerLink
Log in

CANCER IMMUNOTHERAPY

Microbial metabolite boosts immunotherapy

  • Research Highlight
  • Published:

From Nature Reviews Immunology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Original article

  • Mager, L. F. et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science 369, 1481–1489 (2020)

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nature Reviews Immunology http://www.nature.com/nri/

    Lucy Bird

Authors
  1. Lucy Bird
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lucy Bird.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bird, L. Microbial metabolite boosts immunotherapy. Nat Rev Immunol 20, 648–649 (2020). https://doi.org/10.1038/s41577-020-00465-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41577-020-00465-z

  • Springer Nature Limited

This article is cited by

Search

Navigation